Literature DB >> 7614782

Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus.

V A Danis1, M Millington, V Hyland, R Lawford, Q Huang, D Grennan.   

Abstract

The frequency of the uncommon allele (TNF2) of a polymorphism in the promoter region of the tumour necrosis factor alpha (TNF alpha) gene in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) was found to be 3 times that of the normal anglo-saxon population. In SLE patients, this allele was strongly associated with HLA-DR3 expression and was also more frequent in patients who did not have malar rash. Functional studies of normal monocyte cytokine production in vitro showed that this genotype was associated with increased IL-1 alpha protein production but there were no differences in the production of TNF alpha protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614782     DOI: 10.1155/1994/756247

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  23 in total

1.  Association of TNF-α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis.

Authors:  Hai-Feng Pan; Rui-Xue Leng; Chao Wang; Wei-Zi Qin; Li-Li Chen; Zhen-Qiu Zha; Jin-Hui Tao; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2011-04-16       Impact factor: 2.631

2.  Cytogenetic microarray in structurally normal and abnormal foetuses: a five year experience elucidating increasing acceptance and clinical utility.

Authors:  Meenakshi Lallar; Priyanka Srivastava; Archana Rai; Deepti Saxena; Kausik Mandal; Shubha R Phadke
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

3.  Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.

Authors:  Jelena Basic; Dusica Pavlovic; Tatjana Jevtovic-Stoimenov; Jelena Vojinovic; Gordana Susic; Ivana Stojanovic; Gordana Kocic; Vuk Milosevic; Tatjana Cvetkovic; Milena Marinkovic; Andrej Veljkovic
Journal:  J Physiol Biochem       Date:  2010-07-02       Impact factor: 4.158

4.  Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.

Authors:  C E Jackson; R E Fischer; A P Hsu; S M Anderson; Y Choi; J Wang; J K Dale; T A Fleisher; L A Middelton; M C Sneller; M J Lenardo; S E Straus; J M Puck
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 5.  Association of susceptible genetic markers and autoantibodies in rheumatoid arthritis.

Authors:  Vasanth Konda Mohan; Nalini Ganesan; Rajasekhar Gopalakrishnan
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

6.  Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection.

Authors:  Theresa M Karplus; Selma M B Jeronimo; Haeok Chang; Bethany K Helms; Trudy L Burns; Jeffrey C Murray; Adele A Mitchell; Elizabeth W Pugh; Regina F S Braz; Fabiana L Bezerra; Mary E Wilson
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Tumour necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis.

Authors:  Zahra Rezaieyazdi; Jalil Tavakol Afshari; Mahnaz Sandooghi; Farnaz Mohajer
Journal:  Rheumatol Int       Date:  2007-08-29       Impact factor: 2.631

8.  Tumor necrosis factor alpha -308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China.

Authors:  Ruiwen Chen; Meng Fang; Qing Cai; Shiwei Duan; Ke Lv; Ning Cheng; Daming Ren; Jie Shen; Dongyi He; Lin He; Shuhan Sun
Journal:  Rheumatol Int       Date:  2007-08-21       Impact factor: 2.631

Review 9.  IL-10 and TNFalpha genotypes in SLE.

Authors:  Patricia López; Carmen Gutiérrez; Ana Suárez
Journal:  J Biomed Biotechnol       Date:  2010-06-21

10.  Lack of association of tumor necrosis factor alpha gene polymorphism in patients with rheumatoid arthritis in central Taiwan.

Authors:  Sui-Foo Lo; Chung-Ming Huang; Mei-Chen Wu; Jer-Yuarn Wu; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2003-05-16       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.